126 related articles for article (PubMed ID: 15480402)
1. Bisphosphonates for the treatment of Charcot neuroarthropathy.
Anderson JJ; Woelffer KE; Holtzman JJ; Jacobs AM
J Foot Ankle Surg; 2004; 43(5):285-9. PubMed ID: 15480402
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
Selby PL; Young MJ; Boulton AJ
Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
[TBL] [Abstract][Full Text] [Related]
4. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment of Charcot neuroosteoarthropathy.
Jostel A; Jude EB
Clin Podiatr Med Surg; 2008 Jan; 25(1):63-9, vi-vii. PubMed ID: 18165112
[TBL] [Abstract][Full Text] [Related]
6. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
[TBL] [Abstract][Full Text] [Related]
7. Charcot neuro-osteoarthropathy-current standards.
Petrova NL; Edmonds ME
Diabetes Metab Res Rev; 2008; 24 Suppl 1():S58-61. PubMed ID: 18442182
[TBL] [Abstract][Full Text] [Related]
8. Charcot neuroarthropathy in diabetes mellitus.
Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
[TBL] [Abstract][Full Text] [Related]
9. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Al-Nammari SS; Timothy T; Afsie S
Foot Ankle Surg; 2013 Dec; 19(4):212-7. PubMed ID: 24095226
[TBL] [Abstract][Full Text] [Related]
10. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
DiMeglio LA; Ford L; McClintock C; Peacock M
Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
[TBL] [Abstract][Full Text] [Related]
11. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture.
Chantelau E
Diabet Med; 2005 Dec; 22(12):1707-12. PubMed ID: 16401316
[TBL] [Abstract][Full Text] [Related]
12. Acellular fetal bovine dermal matrix for treatment of chronic ulcerations of the midfoot associated with Charcot neuroarthropathy.
Kavros SJ
Foot Ankle Spec; 2012 Aug; 5(4):230-4. PubMed ID: 22715495
[TBL] [Abstract][Full Text] [Related]
13. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
14. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.
Pakarinen TK; Laine HJ; Mäenpää H; Mattila P; Lahtela J
Diabetes Care; 2011 Jul; 34(7):1514-6. PubMed ID: 21593295
[TBL] [Abstract][Full Text] [Related]
15. Healing of Charcot's joint by pamidronate infusion.
Guis S; Pellissier JF; Arniaud D; Turck F; Witjas T; Roux H; Mattei JP
J Rheumatol; 1999 Aug; 26(8):1843-5. PubMed ID: 10451089
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
Pectasides D; Nikolaou M; Farmakis D; Kanakis I; Gaglia A; Kountourakis P; Karamanos NK; Economopoulos T; Raptis SA
Anticancer Res; 2005; 25(2B):1457-63. PubMed ID: 15865105
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.
Richard JL; Almasri M; Schuldiner S
Diabetologia; 2012 May; 55(5):1258-64. PubMed ID: 22361982
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and acute Charcot neuroarthropathy--a call for heightened vigilance.
Iheonunekwu N; Ibrahim TM; Ojuro I
Niger J Med; 2010; 19(2):239-40. PubMed ID: 20642098
[No Abstract] [Full Text] [Related]
19. Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
de Lemos ML; Taylor SC; Barnett JB; Hu F; Levin A; Moravan V; O'Reilly SE
J Oncol Pharm Pract; 2006 Dec; 12(4):193-9. PubMed ID: 17156591
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]